Ponatinib: Uses, Benefits, Dosage, and Side Effects Ponatinib is a prescription medication used to treat certain types of leukemia. Marketed under the brand name Iclusig, Ponatinib is a tyrosine kinase…
Gilteritinib: Targeted Therapy for FLT3-Mutated AML Gilteritinib is a breakthrough oral medication used in the treatment of acute myeloid leukemia (AML), specifically for patients with a FLT3 gene mutation. As…
Larotrectinib: A Targeted Therapy for TRK Fusion Cancer What is Larotrectinib? Larotrectinib is an oral cancer treatment designed to specifically target NTRK gene fusions, a rare genetic abnormality that can…
Reviews
There are no reviews yet.